Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Backstory: Warren Buffett's Valentine's Day surprise for investors

Published 02/16/2018, 07:55 AM
Updated 02/16/2018, 07:55 AM
© Reuters. FILE PHOTO: Berkshire Hathaway CEO Warren Buffett visits the BNSF booth before the Berkshire Hathaway annual meeting in Omaha

By Lauren Young

NEW YORK (Reuters) - Warren Buffett had a Valentine’s Day surprise for investors in Teva Pharmaceutical (NYSE:TEVA) Industries Ltd (TA:TEVA).   

A regulatory filing with the U.S. Securities and Exchange Commission (SEC), known as a 13F, showed that Buffett’s Berkshire Hathaway Inc (N:BRKa) took a stake in the generic drugmaker in the fourth quarter of 2017. The news pushed Teva shares up more than 10 percent on Feb. 14.

Hedge funds are notably hush hush about their portfolio holdings. Quarterly disclosures offer a look at what influential money managers are buying and selling.

The 13F filings are published on the SEC’s website 45 days after the end of each quarter. Once they land, the Reuters stocks team in Bangalore pulls the data into an excel spreadsheet. Working with our investments team in New York, they look for quarterly changes in stock holdings as well as new positions.

While holdings in bigger companies are headline-worthy, we also watch for positions of more than 20 percent in small or mid-cap companies. It is also news when a hedge fund unwinds an important stake. 

Analyzing what the “smart money” is doing allows us to spot investment themes and trends. For example, in late 2017 big hedge funds made bets on companies poised to take advantage of rising wages and prices.

Greenlight Capital’s David Einhorn added 13 new positions in consumer discretionary companies, including stakes in amusement park company SeaWorld Entertainment Inc (N:SEAS), photo printing service Shutterfly Inc (O:SFLY) and department store Nordstrom Inc . (N:JWN).

Since 13F disclosures come more than a month after the end of quarter, they may not reflect current positions at actively traded hedge funds. But, for more traditional buy-and-hold investors like Buffett, the filings shed a light on investment strategy.

In addition to Teva, Buffett bought more shares of Apple Inc (O:AAPL) in the fourth quarter and sold most of International Business Machines (N:IBM).

“There is value in tracking 13Fs,” says Jennifer Ablan, U.S. Investments editor. "It's one the few documents we have that details what the Big Money is doing in the stock market."

© Reuters. FILE PHOTO: Berkshire Hathaway CEO Warren Buffett visits the BNSF booth before the Berkshire Hathaway annual meeting in Omaha

See story at https://www.reuters.com/article/us-investment-funds-berkshire/berkshire-buys-teva-feels-ibm-blues-as-apple-becomes-top-investment-idUSKCN1FY33P

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.